Search Within

Andrew D Zelenetz

Formats
  1. Meeting Abstract (461)
  2. Journal Article (288)
  3. Research Letter (14)
  4. Book Section (7)
  5. Guidelines (5)
  6. Conference Paper (3)
  7. Correspondence (3)
  8. Editorial (3)
  9. Review (1)
Groups
  1. Center for Hematologic Malignancies (785)
  2. Department of Medicine (785)
  3. Hematologic Malignancies, Division of (785)
  4. Lymphoma (785)
  5. Survivorship Research (234)
  6. Population Sciences Research Program (189)

More Groups

People
  1. Craig Moskowitz (207)
  2. Ariela Noy (188)
  3. Paul Hamlin (187)
  4. Steven Horwitz (169)
  5. David Straus (163)
  6. Maria Palomba (143)

More People

Years
  1. 2025 (8)
  2. 2024 (31)
  3. 2023 (43)
  4. 2022 (30)
  5. 2021 (29)
  6. 2020 (32)

More Years

Publications
  1. Blood (329)
  2. Journal of Clinical Oncology (83)
  3. Journal of the National Comprehensive Cancer Network (35)
  4. British Journal of Haematology (34)
  5. Leukemia and Lymphoma (31)
  6. Annals of Oncology (26)

More Publications

Publishers
  1. American Society of Hematology (341)
  2. American Society of Clinical Oncology (85)
  3. John Wiley & Sons (41)
  4. Harborside Press (35)
  5. Elsevier Inc. (31)
  6. Oxford University Press (31)

More Publishers

Results (785)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mechanistic insights into immune related toxicities in subjects with relapsed/ refractory follicular lymphoma treated with zandelisib
    Meeting Abstract

    Sasi, B. K.; Martindale, S. P.; Shupe, S. J.; Fernandes, S. M.; Yadav, S.; Machado, J. H.; Phillips, T.; Zelenetz, A. D.; Brown, J. R.
    Blood (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of single-agent zandelisib administered by intermittent dosing in patients with relapsed or refractory (R/R) follicular lymphoma (FL): Final results of the tidal phase 2 study
    Meeting Abstract

    Zelenetz, A. D.; Jurczak, W.; Ribrag, V.; Linton, K. M.; Collins, G. P.; Bishton, M.; López Jiménez, J.; Dholaria, B.; Mengarelli, A.; Phillips, T. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders
    Meeting Abstract

    Montoya, S.; Bourcier, J.; Thompson, M. C.; Noviski, M.; Tan, M.; Wang, E.; Mi, X.; Brathaban, N.; Risso, C. B.; Tsai, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of the PI3Kδ inhibitor zandelisib in combination with the BTK inhibitor zanubrutinib in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or mantle cell lymphoma (MCL)
    Meeting Abstract

    Soumerai, J. D.; Diefenbach, C. S.; Samaniego, F.; Kumar, A.; Tsai, M. L.; Asch, A. S.; Jagadeesh, D.; Kenkre, V. P.; Lossos, I. S.; Salman, H.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of zandelisib administered by intermittent dosing (ID) in patients with relapsed or refractory (R/R) follicular lymphoma (FL): Primary analysis of the global phase 2 study TIDAL
    Meeting Abstract

    Zelenetz, A. D.; Jurczak, W.; Ribrag, V.; Linton, K.; Collins, G. P.; López-Jiménez, J.; Reddy, N.; Mengarelli, A.; Phillips, T. J.; Musuraca, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The international consensus classification of mature lymphoid neoplasms: A report from the Clinical Advisory Committee
    Guidelines

    Campo, E.; Jaffe, E. S.; Cook, J. R.; Quintanilla-Martinez, L.; Swerdlow, S. H.; Anderson, K. C.; Brousset, P.; Cerroni, L.; de Leval, L.; Dirnhofer, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Response to “The WHO classification of haematolymphoid tumours” (Editorial)
    Correspondence

    Swerdlow, S. H.; Campo, E.; Arber, D. A.; Cazzola, M.; Cook, J. R.; Döhner, H.; Dreyling, M.; Hasserjian, R. P.; Jaffe, E. S.; Orazi, A.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Genomic profiling for clinical decision making in lymphoid neoplasms
    Journal Article

    de Leval, L.; Alizadeh, A. A.; Bergsagel, P. L.; Campo, E.; Davies, A.; Dogan, A.; Fitzgibbon, J.; Horwitz, S. M.; Melnick, A. M.; Morice, W. G.; more...
    Blood (2022)

    Fulltext@MSK | Save